Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-553-6 | CAS number: 2461-15-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from August 29, 1983 to October 21, 1983
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- guideline test, well performed and detailed information
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of study:
- Maurer optimisation test
- Justification for non-LLNA method:
- The study was performed long before availability of the LLNA protocol.
Test material
- Reference substance name:
- [[(2-ethylhexyl)oxy]methyl]oxirane
- EC Number:
- 219-553-6
- EC Name:
- [[(2-ethylhexyl)oxy]methyl]oxirane
- Cas Number:
- 2461-15-6
- Molecular formula:
- C11H22O2
- IUPAC Name:
- 2-{[(2-ethylhexyl)oxy]methyl}oxirane
- Test material form:
- other: colourless liquid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Auxiliary compounds: Bacto Adjuvant, Complete Freund
Test system
Guinea pigs are the animals of choice for sensitization studies.
The test was performed on 10 male and 10 female guinea pigs of the Pirbright white strain (Tif:DHP) weighing between 259 g to 447 g (~10 weeks old).
Animals received: 19.08.1983, Acclimatisation period: 11 days
The animals were housed individually in Macrolon cages type 3, assigned to the different groups by means of random numbers generated by the random number generator incorporated in the Hewlett-Packard desk computer, identified with individual ear tags, kept at a constant room temperature of 21 ±2 °C, at a relative humidity of 50 ±10% and on a 14 hours light cycle day. A 14 hours light cycle day is necessary to eliminate seasonal variation because the animal rooms are not totally protected from natural sunlight.
The animals received ad libitum standard guinea pig pellets - NAFAG No. 84 6, Gossau SG - and water, supplemented with fresh carrots.
The sensitivity of the strain is controlled every six month with p-phenylenediamine.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: intradermal,20% propylene glycol/ 80% physiological saline;epidermal,vaseline
- Concentration / amount:
- 0.1 % for intradermal application
30 % for epidermal application
Challengeopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: intradermal,20% propylene glycol/ 80% physiological saline;epidermal,vaseline
- Concentration / amount:
- 0.1 % for intradermal application
30 % for epidermal application
- No. of animals per dose:
- 20
- Details on study design:
- During the induction period the animals received one injection every second day (except weekends) to a total of 10 intracutaneous injections of a freshly prepared 0.1% suspension of TK 10529 in 20% propylene glycol/80% saline, homogenized with ultrasound. One control group was treated with the vehicle alone ("negative control").
On the first day, injections of 0.1 mL were administered into the shaved skin of the right flank and the back, while on the following days a single intracutaneous injection was given into the back.
During the second and third week of induction the test material was incorporated in a mixture of the normal vehicle with complete Bacto adjuvant (vehicle: adjuvant = 1 : 1).
Fourteen days after the last sensitizing injection, a challenge injection of 0.1 ml of a freshly prepared 0.1% suspension of TK 10529 in 20% propyleneglycol/80% saline, homogenized with ultrasound, was administered into the skin of the left flank.
Twenty-four hours after each injection during the first week of induction and 24 hours after the challenge injection the reactions were recorded.
The two largest perpendicular diameters (in mm) and the increase in the skin-fold thickness (in mm) were measured and by multiplication of these values a "reaction volume" was obtained (in µl) for each reading from each animal. The mean volume plus one standard deviation of the induction reactions observed in the individual animal in the first week was taken as representing the skin irritation "threshold" for each animal.
Any challenge reaction greater than this threshold value of the induction period was graded as an allergic reaction and the animal termed "positive". The number of positive animals in the test group was compared with the number of positive animals in the control group (treated with the vehicle alone) that showed non-specific reactions of at least the same magnitude ("negative control").
Ten days after the intracutaneous challenge injection a sub-irritant dose of the test compound (30% TK 10529) in vaseline and vaseline alone was applied epicutaneously under, occlusive dressings which were left in place for 24 hours. The reactions were evaluated 24 and 48 hours after removing of the bandages according to the Draize scoring scale. The control group was treated with vaseline and, in at least 10 animals, with TK 10529 in vaseline to check the sub-irritant concentration of the test compound in adjuvant treated animals. - Challenge controls:
- 0.1 mL vaseline, 20 animals
- Positive control substance(s):
- yes
- Remarks:
- p-phenylenediamine
Results and discussion
- Positive control results:
- no data
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- rechallenge
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- The guinea pig strain is tested every six month with p-phenelendiamine as positive control substance for sensitivity. Sensitivity of the test system was confirmed in the report.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 20% propylene glycol/80% saline,
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading 24 hours after challenge: Group: negative control. Dose level: 20% propylene glycol/80% saline,. No with. + reactions: 2.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.1 % suspension of TK 10529 in 20% prop,ylene glycol/80% saline,
- No. with + reactions:
- 18
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading 24 hours after challenge: Group: test group. Dose level: 0.1% suspension of TK 10529 in 20% propylene glycol/80% saline,. No with. + reactions: 18.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0.1 mL vaseline
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge 24 hours after challenge: Group: negative control. Dose level: 0.1 mL vaseline. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- other: control group: test article treated
- Dose level:
- 30% TK 10529
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge 24 hours after challenge: Group: other: control group: test article treated. Dose level: 30% TK 10529. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 30% TK 10529
- No. with + reactions:
- 19
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge 24 hours after challenge: Group: test group. Dose level: 30% TK 10529. No with. + reactions: 19.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- other: test group: vehicle treated
- Dose level:
- 0.1 mL vaseline
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge 24 hours after challenge: Group: other: test group: vehicle treated. Dose level: 0.1 mL vaseline. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0.1 mL vaseline
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge 48 hours after challenge: Group: negative control. Dose level: 0.1 mL vaseline. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- other: control group: test article treated
- Dose level:
- 30% TK 10529
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge 48 hours after challenge: Group: other: control group: test article treated. Dose level: 30% TK 10529. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 30% TK 10529
- No. with + reactions:
- 17
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge 48 hours after challenge: Group: test group. Dose level: 30% TK 10529. No with. + reactions: 17.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- other: test group: vehicle
- Dose level:
- 0.1 mL vaseline
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge 48 Hours after challenge: Group: other: test group: vehicle. Dose level: 0.1 mL vaseline. No with. + reactions: 0.0. Total no. in groups: 20.0.
Any other information on results incl. tables
A) Incidence of positive animals per group of intradermal challenge injection.
No. of positive animals/
No. of treated animals P
Control group, vehicle control 2/2 0
TK 10529 18/2 0 <0.01
B) Incidence of positive animals per group after occlusive epicutaneous application.
No. of positive animals/
No. of treated animals P
After 24 hours
Control group, vehicle control 0/2 0
TK, 10529 0/1 0
Test group, TK 10529 19/ 20 <0.01
Vehicle control 0/2 0
After 48 hours
Control group, vehicle control 0/2 0
TK 10529 0/1 0
Test group, TK 10529 17/2 0 < 0.01
Vehicle control 0/2 0
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Test substance is considered to possess skin-sensitizing (contact allergenic) potency in albino guinea-pigs.
- Executive summary:
This key study was conducted to assess the allergenic potential of the test article when administered to the skin of guinea pigs using the optimization test.
The intradermal induction of sensitization was carried out with a 0.1% suspension of the test article in 20% propylene glycol/80% saline. The epicutaneous induction of sensitization was conducted under occlusion with the test article at the same concentration above. Two weeks after the epicutaneous induction application the first challenge was completed by epicutaneous application of the test article at 0.1% in 20% propylene glycol/80% saline under occlusive dressing. The animals of the control group were induced with 20% propylene glycol/80% saline and challenged similarly as those of the test group. Ten days after the intracutaneous challenge injection a sub-irritant dose of the test compound (30% TK 10529) in vaseline and vaseline alone was applied epicutaneously under occlusive dressings which were left in place for 24 hours. The control group was treated with vaseline and, in at least 10 animals, with TK 10529 in vaseline to check the sub-irritant concentration of the test compound in adjuvant treated animals. Cutaneous reactions, i.e erythema and oedema formation were evaluated at 24 and 48 hours after removal of the dressing.
90% of the animals of the test group were observed with positive skin reactions after the first challenge treatment with test substance concentration of 0.1% in 20% propylene glycol/80% saline. No positive reactions were observed in the control group. And in the second challenge assay, positive skin reaction of erythema was observed in 19 of 20 animals after 24 hrs of administration, and 17 of 20 animals showed positive reaction after 48 hrs of application.
Under the experimental conditions employed, significant differences between the test group and the vehicle-treated controls were seen after both intradermal and epidermal challenge application of test substance. Therefore, the test substance is considered to possess skin-sensitising (contact allergenic) potency in albino guinea-pigs. The test substance can be classified as skin sensitisation sub-category 1A according to the CLP regulation (Regulation EC No. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.